Fitting of late dynamic [18F]MK6240 PET scans for in vivo tau quantification
- 89 Downloads
Dear Sir,
We read with great interest the comparison by Guehl et al. of different strategies for in vivo quantification of tau aggregates with [18F]MK6240 in patients with Alzheimer’s disease (AD) or mild cognitive impairment (MCI) and in control subjects (CTRL)[1]. This comparison involved compartment modeling analysis including arterial blood sampling, as well as graphical and simplified methods. For all subjects, the preferred compartmental model was a reversible two-tissue model with the blood contribution included as a model parameter (2T4k1v). This model allowed the authors to fit the [18F]MK6240 uptake of MCI/AD patients, revealing a wide dynamic range as compared with CTRL subjects uptake (Fig. 2 by Guehl et al.). It also showed that the corresponding binding patterns were consistent with neurofibrillary tau deposition patterns [1]. In particular, the 2T4k1v model provided distribution volume ratios (DVR) where cerebellar gray matter (CGM) was used as the reference tissue,...
Notes
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
Research involving human participants and/or animals
Not applicable.
Informed consent
Not applicable.
References
- 1.Guehl NJ, Wooten DW, Yokell DL, Moon SH, Dhaynaut M, Katz S, et al. Evaluation of pharmacokinetic modeling strategies for in vivo quantification of tau with the radiotracer [18F]MK6240 in human subjects. Eur J Nucl Med Mol Imaging. 2019;46:2099–111.CrossRefGoogle Scholar
- 2.Laffon E, Calcagni ML, Galli G, Giordano A, Capotosti A, Marthan R, et al. Comparison of three-parameter kinetic model analysis to standard Patlak's analysis in 18F-FDG PET imaging of lung cancer patients. EJNMMI Res. 2018;8:24–32.CrossRefGoogle Scholar
- 3.JCGM. Evaluation of measurement data – guide to the expression of uncertainty in measurement. www.bipm.org. 2008;(September 2008).